TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function

Gut. 2020 Jan;69(1):146-157. doi: 10.1136/gutjnl-2018-316975. Epub 2019 Feb 5.

Abstract

Objective: We explored the hypothesis that TGR5, the bile acid (BA) G-protein-coupled receptor highly expressed in biliary epithelial cells, protects the liver against BA overload through the regulation of biliary epithelium permeability.

Design: Experiments were performed under basal and TGR5 agonist treatment. In vitro transepithelial electric resistance (TER) and FITC-dextran diffusion were measured in different cell lines. In vivo FITC-dextran was injected in the gallbladder (GB) lumen and traced in plasma. Tight junction proteins and TGR5-induced signalling were investigated in vitro and in vivo (wild-type [WT] and TGR5-KO livers and GB). WT and TGR5-KO mice were submitted to bile duct ligation or alpha-naphtylisothiocyanate intoxication under vehicle or TGR5 agonist treatment, and liver injury was studied.

Results: In vitro TGR5 stimulation increased TER and reduced paracellular permeability for dextran. In vivo dextran diffusion after GB injection was increased in TGR5-knock-out (KO) as compared with WT mice and decreased on TGR5 stimulation. In TGR5-KO bile ducts and GB, junctional adhesion molecule A (JAM-A) was hypophosphorylated and selectively downregulated among TJP analysed. TGR5 stimulation induced JAM-A phosphorylation and stabilisation both in vitro and in vivo, associated with protein kinase C-ζ activation. TGR5 agonist-induced TER increase as well as JAM-A protein stabilisation was dependent on JAM-A Ser285 phosphorylation. TGR5 agonist-treated mice were protected from cholestasis-induced liver injury, and this protection was significantly impaired in JAM-A-KO mice.

Conclusion: The BA receptor TGR5 regulates biliary epithelial barrier function in vitro and in vivo through an impact on JAM-A expression and phosphorylation, thereby protecting liver parenchyma against bile leakage.

Keywords: bile acid; biliary epithelium; cholestaticliver diseases; tight junction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile / metabolism
  • Bile Acids and Salts / metabolism
  • Biliary Tract / physiopathology*
  • Cell Adhesion Molecules / metabolism
  • Cells, Cultured
  • Cholestasis, Intrahepatic / metabolism
  • Cholestasis, Intrahepatic / prevention & control*
  • Electric Impedance
  • Epithelium / physiopathology
  • Isonipecotic Acids / pharmacology
  • Isonipecotic Acids / therapeutic use
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oximes / pharmacology
  • Oximes / therapeutic use
  • Permeability
  • Phosphorylation / physiology
  • Receptors, Cell Surface / metabolism
  • Receptors, G-Protein-Coupled / agonists
  • Receptors, G-Protein-Coupled / physiology*
  • Signal Transduction / physiology
  • Tight Junction Proteins / metabolism

Substances

  • 1-(4-(3-(hydroxyimino)-3-(2-methylpyridin-4-yl)-1-o-tolylpropyl)phenyl)piperidine-4-carboxylic acid
  • Bile Acids and Salts
  • Cell Adhesion Molecules
  • F11r protein, mouse
  • Gpbar1 protein, mouse
  • Isonipecotic Acids
  • Oximes
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Tight Junction Proteins